Variant report
Variant | nsv438254 |
---|---|
Chromosome Location | chr13:67512968-67520344 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AL445989.1-14 | chr13:67517880-67518119 | NONHSAT034214 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9540949 | chr13:67512968-67512969 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs190007379 | chr13:67512994-67512995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181187736 | chr13:67513023-67513024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115916145 | chr13:67513055-67513056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540443937 | chr13:67513070-67513071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565462231 | chr13:67513083-67513084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9540950 | chr13:67513090-67513091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs562504041 | chr13:67513091-67513092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148342672 | chr13:67513100-67513101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140538278 | chr13:67513106-67513107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185538025 | chr13:67513140-67513141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112940951 | chr13:67513214-67513215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564826448 | chr13:67513231-67513232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574635836 | chr13:67513250-67513251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550037118 | chr13:67513252-67513253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35385470 | chr13:67513257-67513258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34654816 | chr13:67513282-67513283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569760681 | chr13:67513283-67513284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112404570 | chr13:67513297-67513298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201732999 | chr13:67513315-67513316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371794475 | chr13:67513339-67513340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549073242 | chr13:67513348-67513349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565991386 | chr13:67513355-67513356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534012853 | chr13:67513416-67513417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78705270 | chr13:67513445-67513446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374874291 | chr13:67513448-67513449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576953158 | chr13:67513467-67513468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539774175 | chr13:67513468-67513469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35492055 | chr13:67513502-67513503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556495736 | chr13:67513506-67513507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370276859 | chr13:67513556-67513557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141256412 | chr13:67513557-67513558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs59727350 | chr13:67513583-67513584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59199272 | chr13:67513589-67513590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs57997772 | chr13:67513590-67513591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576150239 | chr13:67513609-67513610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189660174 | chr13:67513618-67513619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561772509 | chr13:67513655-67513656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536667354 | chr13:67513693-67513694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554653284 | chr13:67513694-67513695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199850240 | chr13:67513696-67513697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572020239 | chr13:67513737-67513738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541102938 | chr13:67513741-67513742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369611135 | chr13:67513744-67513745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569409798 | chr13:67513754-67513755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533568025 | chr13:67513759-67513760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369264166 | chr13:67513766-67513767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28452869 | chr13:67513897-67513898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550100405 | chr13:67513917-67513918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530529990 | chr13:67513933-67513934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Schizophrenia | 23813976 | CNVD |
Prostate cancer | 22341455 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:67508600-67513600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr13:67513600-67514400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr13:67513600-67514400 | Enhancers | HMEC | breast |
4 | chr13:67513600-67514800 | Enhancers | HUVEC | blood vessel |
5 | chr13:67514200-67514600 | Enhancers | A549 | lung |
6 | chr13:67518200-67519200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr13:67518600-67519600 | Enhancers | Primary B cells from peripheral blood | blood |
8 | chr13:67518600-67519600 | Enhancers | Dnd41 | blood |
9 | chr13:67518800-67519400 | Enhancers | Primary B cells from cord blood | blood |
10 | chr13:67519400-67520000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |